ATELVIA vs RECLAST

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. ATELVIA and RECLAST are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ATELVIA	RECLAST
Rating	New	68/100
Pharmacy pays	~$73.02 /30	$0.47 /mL
Type	RX	RX
Active ingredient	RISEDRONATE SODIUM	ZOLEDRONIC ACID
Manufacturer	Apil	Sandoz
Dosage forms	Tablet, delayed release	Injectable
Drug class	Bisphosphonate	Bisphosphonate
Boxed warning	None	None
Half-life	about 561 hours — roughly 23 days	—
Treats	Extramammary Paget Disease, Postmenopausal Osteoporosis	Bone Neoplasms, Hypercalcemia, Multiple Myeloma

atelvia reclast

Rating

New

68/100

Pharmacy pays

~$73.02 /30

$0.47 /mL

Type

Active ingredient

RISEDRONATE SODIUM

ZOLEDRONIC ACID

Manufacturer

Apil

Sandoz

Dosage forms

Tablet, delayed release

Injectable

Drug class

Bisphosphonate

Boxed warning

None

Half-life

about 561 hours — roughly 23 days

—

Treats

Extramammary Paget Disease, Postmenopausal Osteoporosis

Bone Neoplasms, Hypercalcemia, Multiple Myeloma

Frequently asked questions

What is the difference between Atelvia and Reclast?

Atelvia contains Risedronate Sodium, while Reclast contains Zoledronic Acid — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.